| Issue Type | Login |
|---|---|
| Country | United States |
| Industry | Login |
| Region | Login |
| Maturity Date | 2050-09-15 |
| Par Value | 2000 |
| Callable | Login |
| Next Call Date | Login |
| Call Type | Login |
| Call Price (%) | Login |
| Series | Login |
| Class | Login |
| Maturity Structure | Login |
| Amount Outstanding (mil) | 750.00 |
| Coupon | 2.8 |
|---|---|
| Coupon Type | Login |
| Coupon Frequency | Login |
| First Coupon Date | Login |
| Last Coupon Date | Login |
| Sinking Fund | Login |
|---|---|
| Security | Login |
| Subordination | Login |
| Debt Type | Login |
| Issue Date | Login |
|---|---|
| Dated Date | Login |
| Issue Size (mil) | 750.000 |
| Min. Piece | Login |
| Min. Increment | Login |
This Regeneron Pharmaceuticals, Inc. corporate note has a 2.80% fixed rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 750.00 million USD and matures on September 15, 2050 with a last coupon date of FEB 28, 2020. |
Regeneron Pharmaceuticals, Inc., founded in 1988 and headquartered in Tarrytown, New York, is a leading biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative medicines for serious diseases. The company's key products include EYLEA, a treatment for eye diseases, and Dupixent, which targets various allergic conditions and asthma.